Table 2.
Characteristics of Follow-Up Survey Respondentsa
| Total (N = 113) | BCS-PtDA (n = 54) | Control (n = 59) | |
|---|---|---|---|
| Age (years), median (IQR) | 40.0 (39.0, 41.0) | 40.0 (39.0, 41.0) | 40.0 (39.0, 42.0) |
| Missing | 0 | 0 | 0 |
| Lifetime breast cancer risk (NCI-BCRAT) (%), median (IQR) | 9.7 (9.5, 12.2) | 10.2 (9.6, 13.2) | 9.6 (9.2, 11.1) |
| Missing | 0 | 0 | 0 |
| Lifetime breast cancer risk (NCI-BCRAT) categories, n (%) | |||
| ≤12 | 84 (74.3) | 35 (64.8) | 49 (83.1) |
| >12 to ≤20 | 24 (21.2) | 15 (27.8) | 9 (15.3) |
| >20 | 5 (4.4) | 4 (7.4) | 1 (1.7) |
| Missing | 0 | 0 | 0 |
| Perceived lifetime risk (per 1,000), median (IQR) | 67.5 (10.0, 300.0) | 25.0 (10.0, 185.0) | 100.0 (10.0, 425.0) |
| Missing | 7 | 3 | 4 |
| Perceived lifetime risk categories, n (%) | |||
| ≤12 | 71 (67.0) | 35 (68.6) | 36 (65.5) |
| >12 to ≤20 | 7 (6.6) | 5 (9.8) | 2 (3.6) |
| >20 | 28 (26.4) | 11 (21.6) | 17 (30.9) |
| Missing | 7 | 3 | 4 |
| Race, n (%) | |||
| Black | 57 (50.4) | 23 (42.6) | 34 (57.6) |
| White | 42 (37.2) | 22 (40.7) | 20 (33.9) |
| Asian | 6 (5.3) | 4 (7.4) | 2 (3.4) |
| Hispanic | 3 (2.7) | 2 (3.7) | 1 (1.7) |
| Other/unknown | 5 (4.4) | 3 (5.6) | 2 (3.4) |
| Clinic affiliation, n (%) | |||
| Family practice | 22 (19.6) | 9 (16.7) | 13 (22.4) |
| Internal medicine | 54 (48.2) | 27 (50.0) | 27 (46.6) |
| Ob/Gyn | 36 (32.1) | 18 (33.3) | 18 (31.0) |
| Missing | 1 | 0 | 1 |
| Education, n (%) | |||
| Less than high school | 3 (2.7) | 1 (1.9) | 2 (3.4) |
| High school graduate or GED | 10 (8.9) | 4 (7.4) | 6 (10.3) |
| Some college or technical school | 29 (25.9) | 12 (22.2) | 17 (29.3) |
| College graduate or beyond | 70 (62.5) | 37 (68.5) | 33 (56.9) |
| Missing | 1 | 0 | 1 |
| Numeracy (SNS) (1–6), median (IQR) | 4.8 (3.5, 5.5) | 4.4 (3.5, 5.6) | 4.8 (3.0, 5.4) |
| Missing | 1 | 0 | 1 |
| Mammography within 1 year, n (%) | |||
| No | 87 (77.0) | 41 (75.9) | 46 (78.0) |
| Yes | 26 (23.0) | 13 (24.1) | 13 (22.0) |
BCS-PtDA, breast cancer screening patient decision-aid; IQR, interquartile range; NCI-BCRAT, National Cancer Institute Breast Cancer Risk Assessment Tool.